Fox, Susan H <br/><br/>
Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Oct 2006 
 - 1578-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.20936  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Basal Ganglia--drug effects<br/>Clinical Trials, Phase II as Topic<br/>Drug Evaluation, Preclinical<br/>Drugs, Investigational--therapeutic use<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Haplorhini<br/>Humans<br/>Treatment Failure